Disclosures A. Liapakis discloses serving on the Advisory Board for Gilead Sciences and receipt of a Gilead Sciences Collaborative Research Grant. I.M. Jacobson discloses consulting for Aligos, Arbutus, Gilead, GSK, Intercept, Madrigal, Merck, Moderna, Precision Biosciences, Vir; receipt of research funding for Astra Zeneca, AusperBio, Cymabay, 89bio, Eli Lilly, Gilead, GSK, Inventiva, Ipsen, Intercept, Madrigal, Merck, Mirum, Novo Nordisk, Rockefeller University (NIH Supported); and serving on the data monitoring committee for Aligos, Altimmune, GSK, and Takeda.